207-521-4 | Sigma-Aldrich

Product Information Sheet - M4765

Arch. Biochem. Biophys, 95, 271 (1961). 14. Achstetter, T. et al., Arch. Biochem. Biophys., 207, 445 (1981). 15. Bru, R. and Walde, P., Eur. J. Biochem. 199, 95 (1991). 16. Roberts

XP725 Antibody Number-Lot Number 071M4826

562 563 564 6.4 493 494 495 496 517 518 519 520 541 542 543 544 565 566 567 568 6.5 497 498 499 500 521 522 523 524 545 546 547 548 569 570 571 572 6.6 501 502 503 504 525

Genetic Modification of Breast Cancer Gene Targets Using ZFN Technology Reveal Differential Responses to Drug Sensitivity

Res 11 (4), R55 (2009). 2. Normanno, N. et al., The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J Cell Physiol 207 (2), 420

XP725 Antibody List Lot 129K4831

P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 577 phospho-PKB (pSer473) P4112 207 AKT1

XP725 Antibody List Lot 129K4830

P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 577 phospho-PKB (pSer473) P4112 207 AKT1

XP725 Antibody List Lot 089K4791

P2482 207 AKT1 M NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 575 Protein Kinase Ba /Akt1 P1601 207 AKT1 P NP_001014431.1,NP_001014432.1 , NP_005154.2, y y y 577 phospho-PKB (pSer473) P4112 207 AKT1

XP725 Antibody List

001101103.1 M y y y 574 Protein Kinase Bα /Akt1 P2482 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1,NP_150233.1 M y y y 575 Protein Kinase Bα /Akt1 P1601 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1

XP725 Antibody List 013M4793

001101103.1 M y y y 574 Protein Kinase Bα /Akt1 P2482 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1,NP_150233.1 M y y y 575 Protein Kinase Bα /Akt1 P1601 207, 11651, 24185 AKT1,Akt1 NP_005154.2,NP_033782.1

Shaping Epigenetics Discovery - Epigenetics Product Selection Brochure

complexes. Description Catalogue No. Phospho-p53 (Ser15) STAR ELISA Kit 17-475 Anti-Chk1 04-207 Anti-Plk1 05-844 Anti-Wee1 06-972 Response to DNA damage is initiated by recognition of

inNovations Newsletter #18

samples B. Purified DNA samples ← 521 bp M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 M M 1 2 3 4 5 6

ExPlore with Confidence: Prestige Antibodies Breast Cancer Research

AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients. Dis Markers 2013; 35(4):207-212. Epub 2013/09/03. 7. Battistella M et al. The High Expression of the microRNA 17–92 Cluster and

List of Antibodies

n/d 203 Cytokeratin peptide 4 C5176 M y n/d n/d 204 Cytokeratin CK5 C7785 M y n/d n/d 205 Cytokeratin peptide 7 C6417 M y n/d n/d 206 Cytokeratin 8.12 C7034 M y n/d n/d 207 Cytokeratin 8.13 C6909 M y n

XP725 Worksheet for Lot Number 071M4826

2 1 2 2 Calnexin C4731 203 2 1 2 3 Calponin C2687 204 2 1 2 4 Calponin C2687 205 2 1 2 5 Calreticulin C4606 206 2 1 2 6 Calreticulin C4606 207 2 1 2 7 Calretinin C7479 208 2 1 2 8

3D BIOPRINTING: Printing a Brighter Future

Halal Certificate

ISOMERS W356506 C39751 HC-24SII865 520. D-DIHYDROCARVONE, NATURAL W356511 C35053 HC-24SIDD17 521. DECANAL W236209 C39738 HC-24SIEP28 522. DECANAL, NATURAL W236217 C36280 HC-24SIDV51 523. DECANOIC

Halal Certificate

ISOMERS W356506 C39751 HC-22SIDG63 520. D-DIHYDROCARVONE, NATURAL W356511 C35053 HC-22SI5B15 521. DECANAL W236209 C39738 HC-22SIQR26 522. DECANAL, NATURAL W236217 C36280 HC-22SIX449 523. DECANOIC

3D BIOPRINTING: Printing a Brighter Future

Nagarajan, N.; Dupret-Bories, A.; Karabulut, E.; Zorlutuna, P.; Vrana, N. E. Biotechnol. Adv. 2018, 36, 521-533. (211) Noor, N.; Shapira, A.; Edri, R.; Gal, I.; Wertheim, L.; Dvir, T. Adv. Sci. 2019, 6

Hallmarks of Cancer - Solutions for life science research

-RIF1 ABC302 Anti-RRM2 ABC106 Anti-TRF1, clone BED5 57-6 04-638 Anti-TRF2, clone 4A794 05-521 ATM/Chk2 Pathway Explorer Antibody MiniPack 15-116 ChIPAb+™ p53 - ChIP Validated Antibody and